340B Rebate Pilot Threatens West Virginia Clinics' Drug Budgets
Cabin Creek Health Systems, a West Virginia safety-net clinic, warns that a federal 340B drug pricing pilot taking effect January 1 will force it to pay full price upfront for drugs and seek manufacturer rebates afterward, rather than receiving discounts immediately. Staff estimate purchasing costs for affected drugs could jump from roughly $100,000 to $750,000 annually, with some drugs costing $1,500 to $5,000 upfront instead of 30 cents. HRSA says the rebate model improves transparency and program integrity by enabling claims-level verification before rebates are paid. The American Hospital Association and Maine Hospital Association sued HHS on October 9 over the changes, estimating $1 billion in added annual administrative costs nationwide, and the shift coincides with new Medicaid work requirements expected to cause coverage losses for thousands of West Virginians.